FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2005394309> ?p ?o ?g. }

• W2005394309 endingPage "160" @default.
• W2005394309 startingPage "155" @default.
• W2005394309 abstract "Occurrence of second primary tumors and metastasis remains the major obstacles to prolonged survival of patients with primary hepatocellular carcinoma (HCC). A somatostatin analogue, octreotide, has been previously reported to inhibit the growth of human HCC xenografts in nude mice through its anti-angiogenic activity. It is therefore important to investigate whether octreotide could prevent second primary hepatomas or distant metastasis following resection of primary HCC. In this study, nude mice, bearing the human HCC xenografts with highly metastatic potential (LCI-D20) in the left liver lobe, underwent tumor resection, and received intraperitoneal administration of octreotide or saline as a control for 35 consecutive days. Compared with the control group, octreotide at the doses of 100 and 200 μg/kg/day significantly inhibited the growth (P < 0.001 and P < 0.001, respectively) and incidence of second primary tumors (P = 0.016 and P = 0.001, respectively), decreased lung metastasis (P < 0.001 and P < 0.001, respectively), and prolonged the life span (P = 0.029 and P = 0.006, respectively). Moreover, intratumoral angiogenesis quantified by microvessel density as well as serum and tissue vascular endothelial growth factor (VEGF) levels were considerably decreased in octreotide-treated animals compared to the control animals. These findings suggest that octreotide may prevent the occurrence of second primary hepatomas and lung metastasis after resection of primary HCC, which may be partially attributed to down-regulation of VEGF and subsequent reduction in tumor angiogenesis. Octreotide administration may be useful as an adjuvant therapy to improve survival of patients with HCC." @default.
• W2005394309 created "2016-06-24" @default.
• W2005394309 creator A5007476830 @default.
• W2005394309 creator A5015741830 @default.
• W2005394309 creator A5018943067 @default.
• W2005394309 creator A5025656383 @default.
• W2005394309 creator A5032159354 @default.
• W2005394309 creator A5033497327 @default.
• W2005394309 creator A5034272114 @default.
• W2005394309 creator A5046597133 @default.
• W2005394309 creator A5061065826 @default.
• W2005394309 creator A5073851139 @default.
• W2005394309 date "2009-01-01" @default.
• W2005394309 modified "2023-10-03" @default.
• W2005394309 title "A Somatostatin Analogue, Octreotide, Inhibits the Occurrence of Second Primary Tumors and Lung Metastasis after Resection of Hepatocellular Carcinoma in Mice" @default.
• W2005394309 cites W1512561726 @default.
• W2005394309 cites W1527341839 @default.
• W2005394309 cites W175518023 @default.
• W2005394309 cites W1815742699 @default.
• W2005394309 cites W1978483208 @default.
• W2005394309 cites W1983552080 @default.
• W2005394309 cites W2020830322 @default.
• W2005394309 cites W2050547979 @default.
• W2005394309 cites W2057376218 @default.
• W2005394309 cites W2059530905 @default.
• W2005394309 cites W2063055774 @default.
• W2005394309 cites W2075196933 @default.
• W2005394309 cites W2081720784 @default.
• W2005394309 cites W2090059480 @default.
• W2005394309 cites W2095985837 @default.
• W2005394309 cites W2109125410 @default.
• W2005394309 cites W2129462305 @default.
• W2005394309 cites W2137282180 @default.
• W2005394309 cites W2151214205 @default.
• W2005394309 cites W2166973314 @default.
• W2005394309 cites W4243625103 @default.
• W2005394309 cites W4250428608 @default.
• W2005394309 cites W4252851641 @default.
• W2005394309 doi "https://doi.org/10.1620/tjem.218.155" @default.
• W2005394309 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19478472" @default.
• W2005394309 hasPublicationYear "2009" @default.
• W2005394309 type Work @default.
• W2005394309 sameAs 2005394309 @default.
• W2005394309 citedByCount "17" @default.
• W2005394309 countsByYear W20053943092012 @default.
• W2005394309 countsByYear W20053943092013 @default.
• W2005394309 countsByYear W20053943092014 @default.
• W2005394309 countsByYear W20053943092016 @default.
• W2005394309 countsByYear W20053943092017 @default.
• W2005394309 countsByYear W20053943092018 @default.
• W2005394309 countsByYear W20053943092020 @default.
• W2005394309 countsByYear W20053943092021 @default.
• W2005394309 countsByYear W20053943092022 @default.
• W2005394309 crossrefType "journal-article" @default.
• W2005394309 hasAuthorship W2005394309A5007476830 @default.
• W2005394309 hasAuthorship W2005394309A5015741830 @default.
• W2005394309 hasAuthorship W2005394309A5018943067 @default.
• W2005394309 hasAuthorship W2005394309A5025656383 @default.
• W2005394309 hasAuthorship W2005394309A5032159354 @default.
• W2005394309 hasAuthorship W2005394309A5033497327 @default.
• W2005394309 hasAuthorship W2005394309A5034272114 @default.
• W2005394309 hasAuthorship W2005394309A5046597133 @default.
• W2005394309 hasAuthorship W2005394309A5061065826 @default.
• W2005394309 hasAuthorship W2005394309A5073851139 @default.
• W2005394309 hasBestOaLocation W20053943091 @default.
• W2005394309 hasConcept C121608353 @default.
• W2005394309 hasConcept C126322002 @default.
• W2005394309 hasConcept C142724271 @default.
• W2005394309 hasConcept C143998085 @default.
• W2005394309 hasConcept C2776297358 @default.
• W2005394309 hasConcept C2778019345 @default.
• W2005394309 hasConcept C2779013556 @default.
• W2005394309 hasConcept C2780283643 @default.
• W2005394309 hasConcept C2780394083 @default.
• W2005394309 hasConcept C2781025020 @default.
• W2005394309 hasConcept C71924100 @default.
• W2005394309 hasConcept C90924648 @default.
• W2005394309 hasConceptScore W2005394309C121608353 @default.
• W2005394309 hasConceptScore W2005394309C126322002 @default.
• W2005394309 hasConceptScore W2005394309C142724271 @default.
• W2005394309 hasConceptScore W2005394309C143998085 @default.
• W2005394309 hasConceptScore W2005394309C2776297358 @default.
• W2005394309 hasConceptScore W2005394309C2778019345 @default.
• W2005394309 hasConceptScore W2005394309C2779013556 @default.
• W2005394309 hasConceptScore W2005394309C2780283643 @default.
• W2005394309 hasConceptScore W2005394309C2780394083 @default.
• W2005394309 hasConceptScore W2005394309C2781025020 @default.
• W2005394309 hasConceptScore W2005394309C71924100 @default.
• W2005394309 hasConceptScore W2005394309C90924648 @default.
• W2005394309 hasIssue "2" @default.
• W2005394309 hasLocation W20053943091 @default.
• W2005394309 hasLocation W20053943092 @default.
• W2005394309 hasOpenAccess W2005394309 @default.
• W2005394309 hasPrimaryLocation W20053943091 @default.
• W2005394309 hasRelatedWork W2007123753 @default.
• W2005394309 hasRelatedWork W2013777072 @default.
• W2005394309 hasRelatedWork W2031504277 @default.
• W2005394309 hasRelatedWork W2083064369 @default.

• next